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Abstract A calmodulin (CaM)-like protein (hCLP) is ex-
pressed in human mammary epithelial cells but appears to be
limited to certain epithelial cells such as those found in skin,
prostate, breast and cervical tissues. A decrease in the expression
of this protein is associated with the occurrence of tumors in
breast epithelium. The structure of hCLP determined to 1.5 A$
resolution by X-ray crystallography shows a distinct 30‡
displacement along the interconnecting central helix, when
compared to the highly conserved structure of vertebrate CaM,
resulting in a difference in the relative orientation of its two
globular domains. Additionally, the electric surface potential
landscape at the target protein binding regions on the two
globular domains of hCLP is significantly different from those of
CaM, indicating that the respective ranges of hCLP and hCaM
target proteins do not fully overlap. Observations that hCLP can
competitively inhibit CaM activation of target proteins also
imply a role for hCLP in which it may also serve as a modulator
of CaM activity in the epithelial cells where hCLP is
expressed. + 2002 Published by Elsevier Science B.V. on be-
half of the Federation of European Biochemical Societies.
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1. Introduction
Calmodulin (CaM) is a highly conserved Ca2þ binding pro-
tein, which is ubiquitous and central in translating Ca2þ levels
into physiological signals. The crystal structures of Ca2þ
bound CaM show that this protein contains two similar do-
main structures linked by an extended K-helix [1^6], each do-
main containing two helix-loop-helix EF-hand Ca2þ binding
motifs. The incorporation of Ca2þ into CaM is essential and
leads to a major conformational change which includes the
opening of a hydrophobic cavity in each globular domain
necessary for target protein recognition [7]. Various modes
of target peptide recognition have been reported [8^15] and
the hydrophobic patches of the globular domains together
with the charged residues around their rims are believed to
be key for target recognition and speci¢city.
A human CaM-like protein (hCLP) has been identi¢ed [16]
and found to have 85% sequence identity compared to human
CaM (hCaM). It has a higher content of basic residues (11 Arg
and seven Lys) compared to hCaM (six Arg and eight Lys),
resulting in an overall more basic protein [17]. Co-immuno-
precipitation data indicate that the main hCLP binding pro-
tein in vivo is an unconventional myosin I species of approx-
imately 116 kDa, suggesting that hCLP functions as a myosin
binding partner in vivo (Yaswen and Hosoda, unpublished
data). Despite the high sequence identity of hCLP and
hCaM, their expressions and biochemical properties are quite
distinct. While the expression of CaM is ubiquitous, the ex-
pression of hCLP is localized to special types of epithelial cells
such as breast, prostate, skin and cervix. In addition, the ex-
pression of this protein in human mammary epithelial cells
decreases drastically in corresponding tumor tissues [18,19].
Activation of target proteins by hCLP is di¡erent from that
of CaM. For example, the activation of CaM-dependent en-
zymes (cAMP phosphodiesterase, calcineurin, nitric oxide syn-
thase, and myosin-light chain kinase) by hCLP is much weak-
er and, in the case of myosin-light chain kinase as a target
protein, it competitively inhibits CaM activation [20].
hCLP is not able to substitute for yeast CaM (yCaM) [21].
Although the amino acid sequences of yCaM and hCLP show
that there are 64 amino acids di¡erent, only three non-con-
served residues (Arg-57, Arg-111, Ala-127) have been found
to a¡ect hCLP’s ability to substitute for yCaM. In CaM, these
residues are located along the rims of its target protein bind-
ing regions. In this paper, we report the 1.5 AG crystal structure
of the hCLP protein that reveals features distinct from those
of CaM: the surface potential landscapes of the globular do-
mains and central helix £exibility of hCLP and CaM are no-
tably di¡erent. These di¡erences are discussed in context to
their interactions with target proteins and their functional
roles.
2. Materials and methods
2.1. Crystallization
hCLP cDNA was ampli¢ed by polymerase chain reaction from
total normal human mammary epithelial cell cDNA and cloned into
a plasmid pET-NB-1 [18]. hCLP was expressed in Escherichia coli and
puri¢ed using phenyl Sepharose CL-4B hydrophobic and DEAE ion
exchange chromatography. Crystals were obtained by the sitting-drop
technique utilizing a vapor di¡usion procedure. In the crystallization
wells, the protein, which was concentrated to 7 mg/ml in 50 mM pH
7.5 Tris bu¡er containing 2 mM CaCl2, was mixed with mother liquor
containing 27% MPD, 15% ethanol, 50 mM CaCl2 and 0.1 M sodium
acetate bu¡er pH 4.5 in a 3:1 volume ratio. Crystals were normally
harvested in 1^2 weeks. Crystals belong to the space group P21212
with unit cell dimensions, a=63.3, b=93.5, c=24.8 AG , K=L= Q=90‡.
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A selenomethionine (SeMet)-substituted form of hCLP protein [22]
was crystallized under conditions similar to those of the native pro-
tein.
2.2. Data collection, phasing, model building, and re¢nement
The molecular structure was determined to about 1.5 AG resolution
by multiple wavelength anomalous dispersion (MAD) techniques us-
ing SeMet-labeled protein (Table 1). Di¡raction data were collected at
the Advanced Light Source (ALS) of the Lawrence Berkeley National
Laboratory under cryo-conditions with mother liquor as cryo-protec-
tant and processed with DENZO/SCALEPACK [23]. The eight sele-
nium sites per asymmetric unit were located with the program SOLVE
[24].
Subsequent phase modi¢cation including solvent £attening was ac-
complished using DM [25] to 1.5 AG resolution, producing an easily
interpretable map (Fig. 1). Model building was performed using O
[26]. Energy minimization and simulated annealing-based re¢nement
of the model was performed using the ‘Crystallographic and nuclear
magnetic resonance (NMR) system’ [27]. In the last round of re¢ne-
ment, water was added. A ¢nal R value of 18.3 and an Rfree value of
22.1 were obtained.
3. Results and discussion
3.1. Comparison of hCLP and CaM general architectures
The general structural motif of the hCLP is very similar to
CaM, consisting of a dumbbell-like structure containing two
globular domains connected by a central seven-turn, K-helix
(Fig. 2a,b). The structure contains a total of seven K-helices;
residues 5^20 (helix A), 28^39 (helix B), 44^54 (helix C), 65^92
(helix D), 101^112 (helix E), 117^129 (helix F), and 138^147
(helix G), comprising about 69% of the total amino acid res-
idues. The hCLP central K-helix (helix D) is the most hydro-
philic ; it also has the highest temperature factors that are,
however, signi¢cantly lower than the equivalent values for
hCaM. The N- and C-terminal globular domains consist of
three K-helices each and contain hydrophobic residues acces-
sible to solvent (Fig. 2a,b); their K-carbon backbones are
nearly superimposable. Each globular domain contains two
Fig. 1. Stereoview of the 2MFoM3MFcM electron density map in one of the Ca2þ binding regions (residues 129^140) contoured at 1.5c. Ca2þ ion
is represented as a yellow ball.
Table 1
Data collection and structure re¢nement statistics
Set Space group Wavelength (AG ) Resolution (AG ) Redundancy I/cI Completeness (%) Rsym (%)
MAD
edge P21212 0.9798 30^1.8 (1.83^1.8) 4.93 (4.91) 18.9 (17.9) 97.5 (97.4) 6.1 (9.7)
peak P21212 0.9795 30^1.8 (1.83^1.8) 7.19 (7.15) 25.8 (19.9) 100.0 (100.0) 7.2 (14.5)
distant P21212 0.9649 30^1.8 (1.83^1.8) 6.83 (6.8) 23.7 (13.2) 99.9 (100.0) 6.3 (17.2)
Native P21212 1.000 20^1.5 (1.53^1.5) 5.57 (2.58) 30.5 (5.0) 97.7 (78.7) 4.3 (20.8)
Re£ections in working set 22 600
Re£ections in test set 1 153
Rfree (%) 22.1
R (%) 18.3
R.m.s. bond lengths (AG ) 0.0097
R.m.s. bond angles (‡) 1.64
Number of non-hydrogen atoms 1 142
Number of solvent atoms 200
Ramachandran plot (%)
residues in most favored regions 96.1
residues in additional allowed regions 3.9
Average B factor (AG )
main chain 14
side chain 20
Rsym =4MI3GIfM/4I, where I is the measurement of intensity. R=4MFobs3FcalcM/4Fobs for all values where Fobs is the observed native amplitude
and Fcalc is the one calculated from atomic models. Rfree is the R value for 5% of the total re£ections that were excluded in re¢nement. The
values for the highest resolution zone are shown in parentheses.
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Fig. 2. Schematic diagrams, sequence comparison, and Ramachandran plots. a: Superposition of hCLP and four CaMs in ribbon diagram for-
mat. Each molecule is shown in a di¡erent color (hCLP, purple; hCaM, light blue; rCaM, cyan; Drosophila CaM (dCaM), light green; Para-
mecium CaM (pCaM), gray). b: Side and top view of a superposition of hCLP and hCaM. K-Helices are shown as cylinders and labeled
(hCaM is labeled black and hCLP red) alphabetically from the N- to C-terminus. Ca2þ ions are shown as balls and labeled numerically begin-
ning at the N-terminus. hCaM is shown in translucent white while hCLP polypeptides are colored blue to red from the N- to C-terminus and
hCLP Ca2þ ions are colored yellow. The two molecules are brought into register using the K-carbons from C-terminal amino acid residues 93^
147. For the side view, the two molecules are oriented so that the central helix D of hCaM is positioned parallel to the plane of the paper.
The D helices of hCaM and hCLP are displaced by 30‡. For the top view, the two molecules are rotated around the axis shown as the red ar-
row. Helix D of hCaM is hidden from the view and the helix axis is denoted by a black circle. For the top view, only the N-terminal domains
and central helix D are labeled. c: The sequence comparison of hCLP and CaMs from human, yeast, rat, Drosophila, and Paramecium. Large
letters indicate amino acid residues which are di¡erent from hCaM. Three residues, which were studied by point mutation in hCLP, are written
in large bold letters. Amino acid residues which make contact with target peptides in hCaM from four published CaM and peptide [8^11] are
shown in colored boxes. The amino acid residues which make contact with target peptides in all four published complex structures are colored
red, three purple, two pink, and one yellow. d: Ramachandran plot of the central helix (residues 65^92) for hCLP, hCaM and pCaM. The ¢ve
residues in the central part of the helix (amino acid residues 77^81), which has been shown to be the most £exible region in CaM by NMR
studies, are denoted by white squares and are labeled in the case of hCaM and pCaM. The ¢gures (a) and (b) were produced using the pro-
gram MOLSCRIPT [28] and Raster3D [29].
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EF-hand (helix-loop-helix) motifs which form the four Ca2þ
binding sites.
While at the K-carbon backbone level the globular domains
of hCLP and various CaMs are very similar, signi¢cant di¡er-
ences can be found in their central helix regions (Table 2). The
root mean square (r.m.s.) deviation between hCLP and the
CaMs is greatest along the central helix despite the fact that
this is also the region of highest sequence homology. When
the C-terminal globular domains of hCLP and hCaM are
superimposed, there is a 30‡ o¡set of the N-terminal globular
domains between the two molecules as shown in Fig. 2b. This
o¡set is brought about by the di¡erence in the curvatures of
the central helices and a di¡erence in the orientation of the
globular domains about the hinge regions.
3.2. Central helix
As mentioned above, the central helix (Phe-65^Phe-92) of
hCLP is substantially di¡erent from that of CaM and shows a
signi¢cant relative displacement (Fig. 1a). The mobile nature
of the central helix of CaM has been well documented. NMR
studies of CaM have shown that the middle region of the
central helix (Lys-77^Ser-81) is quite £exible [30] ; the crystal-
lographic hCaM data show that residues Thr-79^Ser-81 of
hCaM adopt a non-ideal K-helical conformation and have
the highest temperature factors (B=44 AG 2) [4], supporting
dynamic conformational changes that allow for the two glob-
ular domains to interact with target proteins. In contrast,
temperature factors of the corresponding residues in hCLP
are signi¢cantly lower (B=19 AG 2). The lower temperature
factor of this region in hCLP is not likely to be the result
of crystal packing since it is not involved in the formation
of crystal contacts. Furthermore, the central helix (residues
65^92) of hCLP has a more uniform helical structure than
the corresponding regions of hCaM with psi and phi angles
close to the ideal values of 339.4‡ and 365.3‡ respectively
(Fig. 2d). The distribution of psi and phi angles in this region
of the pCaM model structure even at near atomic resolution
(1.0 AG ) is signi¢cantly broader than those from the corre-
sponding region of the hCLP model structure, further suggest-
ing that the central helix of hCLP is less £exible compared to
CaM.
The £exible and unwinding nature of the central helix mid-
dle region is clearly critical for the ability of CaM to wrap
around proteins and accommodate various kinds of targets. A
reduction in this £exibility would therefore alter the ability of
the globular domains to move relative to each other and at-
tain the conformation necessary for binding to target peptides.
This di¡erence in £exibility may result in a signi¢cant di¡er-
ence in the types of hCLP and CaM target protein interac-
tions possible. Interestingly, the recent structure of CaM com-
plexed with anthrax edema factor reveals a relatively extended
form of CaM bound to its target indicating that a ‘wrapping’
mechanism is not the only mode of binding leading to target
activation [14].
3.3. Globular domains
Within the target protein binding regions of the globular
domains, hCLP contains several residues that are di¡erent
from those found in CaM (Figs. 3 and 4). hCaM residue
Glu-127, located on the rim of the target protein binding
region of the C-terminal globular domain, has been found
to make a salt bridge with an Arg residue on its target pep-
tide. The replacement of Glu-127 with Ala, as found in hCLP,
a¡ects not only Ca2þ binding a⁄nity but also changes the
electric potential landscape of one of its target protein binding
regions clearly in£uencing the nature of target proteins it can
successfully interact with. In fact, it has been shown that
phosphorylation of Ser-458 of CaM target protein Ca2þ/
CaM-dependent protein kinase kinase (CaMKK) abolishes
CaMKK activity [31,32]; Ser-458 is located in close proximity
Table 2
R.m.s. (AG ) ¢t comparison of various hCLP and CaM backbone regions
Protein (PDB ID) Source Resolution (AG ) Residue number R.m.s. ¢t (AG ) Sequence identity (%)
hCaM (1CLL) human 1.7
N-domain 4^64 0.0 100
Central helix 65^92 0.0 100
C-domain 93^147 0.0 100
Total 4^147 0.0 100
rCaM (3CLN) rat 2.2
N-domain 5^64 0.19 100
Central helix 65^92 0.30 100
C-domain 93^147 0.23 100
Total 5^147 0.28 100
dCaM (4CLN) Drosophila 2.2
N-domain 4^64 0.89 100
Central helix 65^92 0.38 100
C-domain 93^147 0.62 94.5
Total 4^147 0.77 98.0
pCaM (1EXR) Paramecium 1.0
N-domain 4^64 0.99 98.4
Central helix 65^92 0.92 75.0
C-domain 93^147 0.73 85.5
Total 4^147 1.05 88.4
hCLP (1GGZ) human 1.5
N-domain 4^64 1.12 83.6
Central helix 65^92 1.33 92.9
C-domain 93^147 0.61 80.0
Total 4^147 3.84 84.4
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to Glu-127 and its phosphorylation would destabilize the salt
bridge formed between Glu-127 and its binding partners on
CaMKK [11]. These results suggest that target proteins that
are selective for hCLP would likely contain residues that allow
for favorable interactions with Ala-127. In the hCLP struc-
ture, residues Arg-57 and Arg-111 are also located at the
periphery of the target protein binding regions of the N-ter-
minal and C-terminal globular domains respectively (Figs. 3
and 4). Since charged residues at the vicinity of the binding
domains in CaM are known to play an important role in CaM
target protein binding, replacement of uncharged residues
(Ala-57 and Asn-111 of hCaM) with positively charged Arg
can be expected to a¡ect the target protein binding interac-
tions as well as Ca2þ binding a⁄nity. It is therefore not sur-
prising that point mutation studies in yeast show that residues
Glu-127, Ala-57 and Asn-111 are important for the activity of
CaM [21] in cell growth.
In addition to the above three non-conservatively substi-
tuted residues, there are several conservative substitutions.
In the C-terminal globular domain of hCaM residues Met-
144, Met-145 and Ile-100, which are positioned within the
hydrophobic patch of the target binding region, are replaced
Fig. 3. Space ¢lling representation of hCaM and hCLP with the emphasis on target peptide binding sites. Amino acid residues, which are dif-
ferent in hCaM and hCLP, are labeled. Three residues (Arg-57, Arg-111, Ala-127) in hCLP, which have been studied by point mutation in
yeast, have cyan-colored labels. For (a) and (b), the same coloring scheme as Fig. 2c has been used for the amino acid residues which make
contact with target peptides. In (c) and (d), a similar color scheme has been used for the corresponding amino acid residues but only those res-
idues which are di¡erent in both molecules are colored for simplicity. a: N-terminal globular domain (residues 4^70) of hCaM. b: C-terminal
globular domain (residues 78^147) of hCaM. c: N-terminal globular domain of hCLP. d: C-terminal globular domain of hCLP.
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in hCLP by Val, Leu and Val respectively (Fig. 3). In the N-
terminal globular domain, residues Ile-52, Val-55 and Ile-63 of
hCaM, which again are all positioned within the hydrophobic
patch of a target binding region, are replaced respectively with
Met, Ile and Val in hCLP (Fig. 3). Similar conservative sub-
stitutions are also found in fully functional yCaM and appear
to be well tolerated without signi¢cant alteration of CaM
function.
The di¡erences in globular domain residues, particularly
those located within the target protein binding regions of
the globular domains, are expected to a¡ect the four Ca2þ
binding sites. It has been reported that there is a 10-fold
weaker Ca2þ binding a⁄nity in hCLP compared to hCaM
[17]. Since the K-carbon backbones of globular domains of
hCLP and hCaM are highly conserved, the di¡erence in
Ca2þ binding is likely to be the result of the relatively smaller
negative surface charge of the hCLP globular domains. A
simple electric potential energy calculation (based on AMBER
electrostatic parameters [33]) indicates that the relative bind-
ing energies of Ca2þ for the N- and C-terminal domains of
hCLP are signi¢cantly smaller than those for the equivalent
domains of hCaM. hCLP’s weaker binding a⁄nity for Ca2þ
suggests that it has a di¡erent Ca2þ-mediated response as
compared to CaM. It appears then that under normal phys-
Fig. 4. Space ¢lling representation of hCaM and hCLP in the same orientation as Fig. 3 but with an emphasis on the electric potential land-
scapes around the peptide binding sites. Residues which are known to be involved in target peptide binding from previous structural studies of
CaM and residues which di¡er in hCLP and hCaM are all shown as solid spheres: other residues are shown as translucent spheres. The carbon
atoms are colored white, carboxyl oxygens red, other oxygens pink, nitrogens from arginines blue, other nitrogens light blue, and sulfurs yel-
low. The ¢gures were prepared in the same orientation as in Fig. 3. Charged residues are labeled. a: N-terminal globular domain (residues 4^
70) of hCaM. b: C-terminal globular domain (residues 78^147) of hCaM. c: N-terminal globular domain of hCLP. d: C-terminal globular do-
main of hCLP. The glutamic acids identi¢ed in (a) and (b) are known to frequently interact with residues of the target peptides as discussed in
the text. These residues add an additional dimension of £exibility in target selection.
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iological levels of Ca2þ, hCLP could compete for binding with
CaM target proteins in circumstances where target binding
does not require the presence of Ca2þ in the binding globular
domains. Radically decreased expression levels of hCLP, such
as those found in breast tumor tissues [18], together with its
unique electric potential landscapes and less £exible central
helix, would therefore be expected to a¡ect any CaM modu-
lation role. Along this line, it is interesting to note that a
decrease in the expression level of hCLP is associated with
early events in breast cancer development [19].
Of the various proteins from which the structures of their
complexes with CaM have been determined [8^14], two, CaM
kinase II and myosin-light chain kinase, have been studied for
their interaction with hCLP [20]. hCLP activates CaM kinase
II and competitively inhibits CaM-dependent activation of
myosin-light chain kinase while CaM activates both proteins.
The di¡erences in target protein interactions are likely the
result of the di¡erence in the mobility of central helix that
may prevent activation of certain targets by hCLP and/or
residue substitutions that alter the electrical potential land-
scape of the target protein binding domains as well as Ca2þ
binding a⁄nity.
In summary, the structural di¡erences of hCLP and CaM,
especially as re£ected in the electric potential landscapes, have
provided insight into probable functional properties of hCLP.
Altering charged residues along the rim of the target binding
domains modi¢es the range and strength of interaction with
target proteins. The presence of more basic residues in the
target protein binding domains of hCLP, a¡ecting both
Ca2þ and target protein binding, and the lower £exibility of
the CLP central helix suggest the existence of hCLP speci¢c
target proteins and a potential role in CaM activity modula-
tion. The presence of hCLP target proteins in the epithelial
cells in which they are speci¢cally expressed has yet to be
¢rmly established, although an unconventional myosin I spe-
cies has been found to be one possible candidate (Yaswen and
Hosoda, unpublished results).
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